1. Shaw JE, Zimmet PZ. The epidemiology of diabetic neuropathy. Diabetes Rev 1999; 7:245-252.

2. Tesfaye S, Stephens L, Stephenson J, et al. The prevalence of diabetic neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996;39:1377-1384.

3. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-154.

4. Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989;38:1456-1461.

5. Ziegler D. Diagnosis, staging and epidemiology of diabetic peripheral neuropathy. Diab Nutr Metab 1994;7:342-348.

6. Tesfaye S, Chaturvedi N, Eaton SEM, Witte D, Ward JD, Fuller J. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:341-350.

7. Boulton AJM, Kirsner RS, Viliekyte L. Neuropathic diabetic foot ulcers. N Engl J Med 2004;351:48-55.

8. Tesfaye S. Diabetic neuropathy: achieving best practice. Br J Vasc Dis 2003;3:112-117.

9. Watkins PJ, Edmonds ME. Clinical features of diabetic neuropathy, in Textbook of Diabetes (Pickup J, Williams G, eds.), 1997, Vol. 2, pp. 50.1-50.20.

10. Ward JD. Clinical features of diabetic neuropathy. in Diabetic Neuropathy (Ward JD, Goto Y, eds.), Chichester, UK., Wiley, 1990, pp. 281-296.

11. Bruyn GW, Garland H. Neuropathies of endocrine origin. in Handbook of clinical neurology (Vinken PJ, Bruyn GW, eds.), Amsterdam, North-Holland Publishing Co., 1970, Vol. 8, 29p.

12. Thomas PK. Metabolic neuropathy. J Roy Coll Phys (Lond) 1973;7:154-160.

13. Low PA, Suarez GA. Diabetic neuropathies. in Bailliere's Clinical Neurology 1995;4(3):401-425.

14. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM. Diabetic Somatic neuropathies. Diabetes Care 2004;27:1458-1486.

15. Eaton SEM, Tesfaye S. Clinical manifestations and measurement of somatic neuropathy. Diabetes Rev 1999;7:312-325.

16. Scott LA, Tesfaye S. Measurement of somatic neuropathy for clinical practice and clinical trials. Curr Diabetes Rep 2001;1:208-215.

17. Andersen H, Jakobsen J. Motor function in diabetes. Diabetes Rev 1999;7:326-341.

18. Watkins PJ. Pain and diabetic neuropathy. Br Med J 1984;288:168-169.

19. Tesfaye S, Price D. Therapeutic approaches in diabetic neuropathy and neuropathic pain. in Diabetic Neuropathy. (Boulton AJM, ed.), 1997;159-181.

20. Tesfaye S, Watt J, Benbow SJ, Pang KA, Miles J, MacFarlane IA. Electrical spinal cord stimulation for painful diabetic peripheral neuropathy. Lancet 1996;348:1696-1701.

21. Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev 2003;(Suppl 1):S1-S8.

22. Ewing DJ, Borsey DQ, Bellavere F, Clarke BF. Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation. Diabetologia 1981;21:18-24.

23. Ward JD. The diabetic leg. Diabetologia 1982;22:141-147.

24. Rajbhandari SM, Jenkins R, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia 2002;1085-1096.

25. Ward JD, Simms JM, Knight G, Boulton AJM, Sandler DA. Venous distension in the diabetic neuropathic foot (physical sign of arterio-venous shunting). J Roy Soc Med 1983;76:1011-1014.

26. Boulton AJM, Scarpello JHB, Ward JD. Venous oxygenation in the diabetic neuropathic foot: evidence of arterial venous shunting? Diabetologia 1982;22:6-8.

27. Edmonds ME, Archer AG, Watkins PJ. Ephedrine: a new treatment for diabetic neuropathic oedema. Lancet 1983;1(8324):548-551.

28. Said G, Slama G, Selva J. Progressive centripital degeneration of of axons in small-fibre type diabetic polyneuropathy. A clinical and pathological study. Brain 1983;106:791.

29. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia 2000;43:957-973.

30. Veves A, Young MJ, Manes C, et al. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy: a Clinical study. Diabetes Care 1994;17:1200-1202.

31. Ward JD, Tesfaye S. Pathogenesis of diabetic neuropathy. in Textbook of Diabetes (Pickup J, Williams G, eds.), 1997, Vol. 2, pp. 49.1- 49.19.

32. Cameron NE, Eaton SE, Cotter MA, Tesfaye S.Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001;44:1973-1988.

33. Tesfaye S, Harris N, Jakubowski J, et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 1993;36:1266-1274.

34. Eaton SE, Harris ND, Ibrahim S, et al. Differnces insural nerve haemodynamics in painful and painless neuropathy. Diabetologia 2003;934-939.

35. Malik RA, Tesfaye S, Newrick PG, et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005;48:578-585.

36. Boulton AJM, Armstrong WD, Scarpello JHB, Ward JD. The natural history of painful diabetic neuropathy - a 4 year study. Postgrad Med J 1983;59:556-559.

Benbow SJ, Chan AW, Bowsher D, McFarlane IA, Williams G. A prospective study of painful symptoms, small fibre function and peripheral vascular disease in chronic painful diabetic neuropathy. Diabetic Med 1994;11:17-21.

Chan AW, MacFarlane IA, Bowsher DR, Wells JC, Bessex C, Griffiths K. Chronic pain in patients with diabetes mellitus: comparison with non-diabetic population. Pain Clin 3 1990;147-159.

Young RJ, Zhou YQ, Rodriguez E, Prescott RJ, Ewing DJ, Clarke BF. Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy. Diabetes 1986;35:192-197.

Tsigos C, White A, Young RJ. Discrimination between painful and painless diabetic neuropathy based on testing of large somatic nerve and sympathetic nerve function. Diabetic Med 1992;9:359-365.

Veves A, Manes C, Murray HJ, Young MJ, Boulton AJM. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care 1993;16:1187-1189. Young MJ, Manes C, Boulton AJM. Vibration perception threshold predicts foot ulceration: a prospective study (Abstract). Diabetic Med 1992;9(Suppl 2):542. Tesfaye S, Kempler P. Painful diabetic neuropathy. Diabetologia 2005;48:805-807. Archer AG, Watkins PJ, Thomas PJ, Sharma AK, Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neorosurg Psychiatr 1983;46:491-496. Ellenberg M. Diabetic neuropathic cachexia. Diabetes 1974;23:418-423. Guy RJC, Clark CA, Malcolm PN, Watkins PJ. Evaluation of thermal and vibration sensation in diabetic neuropathy. Diabetologia, 1985;28:131. Caravati CM. Insulin neuritis: a case report. Va MedMon 1933;59:745-746. Tesfaye S, Malik R, Harris N, et al. Arteriovenous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 1996;39:329-335.

Llewelyn JG, Thomas PK, Fonseca V, King RHM, Dandona P. Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol (Berl) 1986;72: 157-163.

Tesfaye S, Harris N, Wilson RM, Ward JD. Exercise induced conduction veolcity increment: a marker of impaired nerve blood flow in diabetic neuropathy. Diabetologia 1992;35:155-159.

Kihara M, Zollman PJ, Smithson IL, et al. Hypoxic effect of endogenous insulin on normal and diabetic peripheral nerve. Am J Physiol 1994;266:E980-E985. Matikainen E, Juntunen J. Diabetic neuropathy: Epidemiological, pathogenetic, and clinical aspects with special emphasis on type 2 diabetes mellitus. Acta Endocrinol Suppl (Copenh) 1984;262:89-94.

Asbury AK, Aldredge H, Hershberg R, Fisher CM. Oculomotor palsy in diabetes mellitus:

a clinicopathological study. Brain 1970;93:555-557.

Garland H. Diabetic amyotrophy. Br Med J 1955;2:1287-1290.

Coppack SW, Watkins PJ. The natural history of femoral neuropathy. Q J Med 1991; 79:307-313.

Casey EB, Harrison MJG. Diabetic amyotrophy: a follow-up study. Br Med J 1972;1:656. Garland H, Taverner D. Diabetic myelopathy. Br Med J 1953;1:1405. Subramony SH, Willbourn AJ. Diabetic proximal neuropathy. Clinical and electromyographic studies. J Neurol Sci 1982;53:293-304.

Bastron JA, Thomas JE. Diabetic polyradiculoneuropathy: clinical and electromyographic findings in 105 patients. Mayo Clinic Proc 1981;56:725-732.

Said G, Goulon-Goeau C, Lacroix C, Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 1994;33:559-569. Haq RU, Pendlebury WW, Fries TJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. Muscle Nerve 2003;27:465-470.

62. Steward JD, McKelvey R, Durcan L, Carpenter S, Karpati G. Chronic inflammatory demyelinating polyneuropathy (CIPD) in diabetes. J Neurol Sci 1996;142:59-64.

63. Koller H, Kieseier BC, Jander S, Hartung H. Chronic Inflammatory Demyelinating Polyneuropathy. NEJM 2005;352:1343-1356.

64. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP): report from an ad hoc sub-committee of the America Academy of Neurology AIDS Task Force. Neurology 1991;41:617-618.

65. Wilson JR, Park Y, Fisher MA. Electrodiagnostic criteria in CIDP: comparison with diabetic neuropathy. Electromyogr Clin Neurophsiol 2000;40:181-185.

66. Molenaar DS, Vermeulen M, de Haan R. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1998;64: 84-89.

67. Gabriel CM, Howard R, Kinsella N, et al. Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry 2000;69:442-446.

68. Vital C, Vital A, Lagueny A, et al. Chronic inflammatory demyelinating polyneuropathy; immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases. Ultrastruct Pathol 2000;24:363-369.

69. Cocito D, Ciaramitaro P, Isoardo G, et al. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP. J Neurol 2002;249:719-722.

70. Sharma KR, Cross J, Ayyar DR, Martinez-Arizala A, Bradley WG. Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy. Arch Neurol 2002; 59:751-757.

71. Zorilla E, Kozak GP. Ophthalmoplegia in diabetes mellitus. Ann Internal Med 1967;67:968-976.

72. Goldstein JE, Cogan DG. Diabetic ophthalmoplegia with special reference to the pupil. Arch Ophthalmol 1960;64:592-600.

73. Leslie RDG, Ellis C. Clinical course following diabetic ocular palsy. Postgrad Med J 1978;54:791-792.

74. Dreyfuss PM, Hakim S, Adams RD. Diabetic ophthalmoplegia. Arch Neurol Psychiatry 1957;77:337-349.

75. Ellenberg M. Diabetic truncal mononeuropathy—a new clincal syndrome. Diabetes Care 1978;1:10-13.

76. Boulton AJM, Angus E, Ayyar DR, Weiss R. Diabetic thoracic polyradiculopathy presenting as abdominal swelling. BMJ 1984;289:798-799.

77. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-824.

78. Clayburgh RH, Beckenbaugh RD, Dobyns JH. Carp[el tunnel release in patients with diffuse peripheral neuropathy. J Hand Surg 1987;12A:380-383.

79. White JES, Bullock RF, Hudgson P, Home PD, Gibson GJ. Phrenic neuropathy in association with diabetes. Diabet Med 1992;9:954-956.

Supplements For Diabetics

Supplements For Diabetics

All you need is a proper diet of fresh fruits and vegetables and get plenty of exercise and you'll be fine. Ever heard those words from your doctor? If that's all heshe recommends then you're missing out an important ingredient for health that he's not telling you. Fact is that you can adhere to the strictest diet, watch everything you eat and get the exercise of amarathon runner and still come down with diabetic complications. Diet, exercise and standard drug treatments simply aren't enough to help keep your diabetes under control.

Get My Free Ebook

Post a comment